231 related articles for article (PubMed ID: 6150232)
1. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
[TBL] [Abstract][Full Text] [Related]
2. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
[TBL] [Abstract][Full Text] [Related]
3. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
[TBL] [Abstract][Full Text] [Related]
4. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
[TBL] [Abstract][Full Text] [Related]
5. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
[TBL] [Abstract][Full Text] [Related]
6. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?
Jenkins RT; Rooney PJ; Jones DB; Bienenstock J; Goodacre RL
Br J Rheumatol; 1987 Apr; 26(2):103-7. PubMed ID: 3103807
[TBL] [Abstract][Full Text] [Related]
7. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
[TBL] [Abstract][Full Text] [Related]
8. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs.
Bjarnason I; Zanelli G; Prouse P; Smethurst P; Smith T; Levi S; Gumpel MJ; Levi AJ
Lancet; 1987 Sep; 2(8561):711-4. PubMed ID: 2888943
[TBL] [Abstract][Full Text] [Related]
9. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease.
Pironi L; Miglioli M; Ruggeri E; Levorato M; Dallasta MA; Corbelli C; Nibali MG; Barbara L
Dig Dis Sci; 1990 May; 35(5):582-8. PubMed ID: 1691967
[TBL] [Abstract][Full Text] [Related]
10. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
[TBL] [Abstract][Full Text] [Related]
11. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man.
Oman H; Blomquist L; Henriksson AE; Johansson SG
Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970
[TBL] [Abstract][Full Text] [Related]
12. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test.
Bjarnason I; Peters TJ; Veall N
Lancet; 1983 Feb; 1(8320):323-5. PubMed ID: 6130333
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability and inflammation in patients on NSAIDs.
Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
[TBL] [Abstract][Full Text] [Related]
14. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis?
Segal AW; Isenberg DA; Hajirousou V; Tolfree S; Clark J; Snaith ML
Br J Rheumatol; 1986 May; 25(2):162-6. PubMed ID: 3085760
[TBL] [Abstract][Full Text] [Related]
16. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives.
Martínez-González O; Cantero-Hinojosa J; Paule-Sastre P; Gómez-Magán JC; Salvatierra-Ríos D
Br J Rheumatol; 1994 Jul; 33(7):644-7. PubMed ID: 8019793
[TBL] [Abstract][Full Text] [Related]
17. 51Cr-EDTA test for intestinal permeability.
Selby P; McElwain TJ; Crofts M; Lopes N; Mundy J
Lancet; 1984 Jul; 2(8393):38-9. PubMed ID: 6145950
[No Abstract] [Full Text] [Related]
18. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
Bjarnason I
J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
[TBL] [Abstract][Full Text] [Related]
19. Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy.
Bjarnason I; Smethurst P; Levi AJ; Peters TJ
Gut; 1985 Jun; 26(6):579-85. PubMed ID: 3924747
[TBL] [Abstract][Full Text] [Related]
20. 51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease.
Fotherby KJ; Wraight EP; Neale G
Scand J Gastroenterol; 1988 Mar; 23(2):171-7. PubMed ID: 3129775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
